References

Bailey D. G., Dresser G., & Arnold J. M. (2013). Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Canadian Medical Association Journal, 185, 309–316.

Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28(3), 309-369. https://doi.org/10.1016/S0165-0173(98)00019-8

Brown, M. J., & Mezuk, B. (2012). Brains, bones, and aging: psychotropic medications and bone health among older adults. Current Osteoporosis Reports, 10, 303–311.

Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J.,  Vallone, D., Saiardi, A., & Borrelli, E. (2002). Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. The Journal of Neuroscience, 22(7), 2977-2988. https://doi.org/10.1523/JNEUROSCI.22-07-02977.2002

Centers for Disease Control and Prevention (CDC) (2011) Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report 61(SS03) 1–19.

Centers for Disease Control and Prevention (CDC) (2013) Mental health surveillance among children – United States, 2005—2011. Morbidity and Mortality Weekly Report 62 Suppl, 1-35.

Centers for Disease Control and Prevention (CDC) (2023). Data & Statistics on Autism Spectrum Disorder. https://www.cdc.gov/ncbddd/autism/data.html

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., … & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946-1949.

Di Chiara, G. (1999). Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology, 375(1–3), 13-30. https://doi.org/10.1016/S0014-2999(99)00372-6

Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America [PNAS] 85(14), 5274-5278. https://doi.org/10.1073/pnas.85.14.5274

Everitt, B. J., & Robbins, T. W. (2016). Drug addiction: Updating actions to habits to compulsions ten years on. Annual Review of Psychology, 67(1), 23-50. https://doi.org/10.1146/annurev-psych-122414-033457

Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001). The neuropsychological basis of addictive behaviour. Brain Research Reviews, 36(2–3), 129-138. https://doi.org/10.1016/S0165-0173(01)00088-1

Franken, I. H. A. (2003). Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27(4), 563-579. https://doi.org/10.1016/S0278-5846(03)00081-2

Goodman, A. (2008). Neurobiology of addiction: An integrative review. Biochemical Pharmacology, 75(1), 266-322. https://doi.org/10.1016/j.bcp.2007.07.030

Heilig, M., MacKillop, J., Martinez, D., Rehm, J., Leggio, L., & Vanderschuren, L. J. M. J. (2021). Addiction as a brain disease revised: Why it still matters, and the need for consilience. Neuropsychopharmacology, 46(10), 1715-1723. https://doi.org/10.1038/s41386-020-00950-y

Hilmer, N., & Gnjidict, D. (2008). The effects of polypharmacy in older adults. Clinical Pharmacology & Therapeutics, 85, 86–88.

Ioannidis, J. P. A. (2008). Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philosophy, Ethics, and Humanities in Medicine, 3,14.

Kalivas, P. W., & Weber, B. (1988). Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. Journal of Pharmacology and Experimental Therapeutics, 245(3), 1095-1102.

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617–627.

Koob, G. F., & Volkow, N. D. (2009). Neurocircuitry of addiction. Neuropsychopharmacology, 35, 217-238. https://doi.org/10.1038/npp.2009.110

Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773. https://doi.org/10.1016/S2215-0366(16)00104-8

Koob, G.F. (2005). The neurocircuitry of addiction: Implications for treatment. Clinical Neuroscience Research, 5(2-4), 89-101. https://doi.org/10.1016/j.cnr.2005.08.005

McKendrick, G., & Graziane, N. M. (2020). Drug-induced conditioned place preference and its practical use in substance use disorder research. Frontiers in Behavioral Neuroscience, 14, 582147. https://doi.org/10.3389/fnbeh.2020.582147

Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M., (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64(9), 1032–1039.

Negus, S. S., & Miller, L. L. (2014). Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacological Reviews, 66(3), 869-917. https://doi.org/10.1124%2Fpr.112.007419

Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419. https://doi.org/10.1037/h0058775

Pollock, B. G., Forsyth, C. E., & Bies, R. R. (2008). The critical role of clinical pharmacology in geriatric psychopharmacology. Clinical Pharmacology & Therapeutics, 85, 89–93.

Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18(3), 247-291. https://doi.org/10.1016/0165-0173(93)90013-P

Robinson, T. E., & Berridge, K. C. (2001). Incentive-sensitization and addiction. Addiction, 96(1), 103-114. https://doi.org/10.1046/j.1360-0443.2001.9611038.x

Rohsenow, D. J., Niaura, R. S., Childress, A. R., Abrams, D. B., & Monti, P. M. (1990). Cue reactivity in addictive behaviors: Theoretical and treatment implications. International Journal of Addiction, 25, 957–993.

Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., … & Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700-1712.

Schultz, W., & Dickinson, A. (2000). Neuronal coding of prediction errors. Annual Review of Neuroscience, 23, 473-500. https://doi.org/10.1146/annurev.neuro.23.1.473

Schwartz, J. B., & Abernethy, D. R. (2008). Aging and medications: Past, present, future. Clinical Pharmacology & Therapeutics, 85, 3–10.

Vezina, P. (1993). Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat. Brain Research, 605(2), 332-337. https://doi.org/10.1016/0006-8993(93)91761-G

Wise, R. A. (1998). Drug-activation of brain reward pathways. Drug and Alcohol Dependence, 51(1–2), 13-22. https://doi.org/10.1016/S0376-8716(98)00063-5

World Health Organization (2004). Promoting mental health: concepts, emerging evidence, practice (Summary Report). Geneva, Switzerland: Author. http://www.who.int/mental_health/evidence/en/promoting_mhh.pdf;

Wyvell, C. L., & Berridge, K. C. (2000). Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: Enhancement of reward “wanting” without enhanced “liking” or response reinforcement. Journal of Neuroscience, 20(21), 8122-8130. https://doi.org/10.1523/JNEUROSCI.20-21-08122.2000

Zhou, S. F. (2009). Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II. Clinical Pharmacokinetics, 48, 761–804.